Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.5M Buy
7,110
+2,020
+40% +$720K 0.62% 28
2025
Q4
$1.67M Sell
5,090
-1,753
-26% -$556K 0.36% 52
2025
Q3
$1.93M Buy
+6,843
New +$1.98M 0.37% 50
2025
Q2
Sell
-5,072
Closed -$1.58M 512
2025
Q1
$1.58M Buy
5,072
+3,496
+222% +$1.03M 0.31% 69
2024
Q4
$411K Buy
+1,576
New +$468K 0.09% 250

Other funds holding AMGN

111 Capital's AMGN Position: Q1 2026 in Review

111 Capital increased its Amgen (AMGN) stake by 40% in Q1 2026, buying an estimated $720K and bringing the position to 7,110 shares worth $2.5M. The position accounts for 0.62% of the portfolio, ranked #28.

111 Capital first reported a position in AMGN in Q4 2024 and has held it in 5 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • 111 Capital held 7,110 shares of Amgen worth $2.5M as of Q1 2026.
  • 111 Capital bought 2,020 Amgen shares in Q1 2026, an estimated $720K.
  • Amgen made up 0.62% of 111 Capital's portfolio in Q1 2026, its #28 holding.
  • 111 Capital first reported a position in Amgen in Q4 2024 and has held it in 5 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on 111 Capital's 13F filing for Q1 2026, filed 11 May 2026.